PortfoliosLab logoPortfoliosLab logo
RGC vs. DFDV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RGC vs. DFDV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regencell Bioscience Holdings Limited (RGC) and DeFi Development Corp (DFDV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RGC achieves a 13.10% return, which is significantly higher than DFDV's -40.30% return.


RGC

1D
2.59%
1M
-13.19%
YTD
13.10%
6M
82.55%
1Y
48.17%
3Y*
242.31%
5Y*
10Y*

DFDV

1D
-8.36%
1M
-29.06%
YTD
-40.30%
6M
-57.83%
1Y
-83.23%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

RGC vs. DFDV - Yearly Performance Comparison


2026 (YTD)202520242023
RGC
Regencell Bioscience Holdings Limited
13.10%16,053.85%-52.95%-35.56%
DFDV
DeFi Development Corp
-40.30%700.93%-41.08%-73.04%

Correlation

The correlation between RGC and DFDV is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Jul 26, 2023

0.01

The correlation between RGC and DFDV shifts across timeframes, from 0.01 (all time) to 0.14 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

RGC:

$11.74B

DFDV:

$79.17M

EPS

RGC:

-$0.02

DFDV:

-$6.55

PB Ratio

RGC:

9.63K

DFDV:

7.77

Total Revenue (TTM)

RGC:

$0.00

DFDV:

$13.76M

Gross Profit (TTM)

RGC:

-$40.84K

DFDV:

$13.42M

EBITDA (TTM)

RGC:

-$8.81M

DFDV:

-$117.94M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RGC vs. DFDV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RGC
RGC Risk / Return Rank: 6565
Overall Rank
RGC Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
RGC Sortino Ratio Rank: 9191
Sortino Ratio Rank
RGC Omega Ratio Rank: 9090
Omega Ratio Rank
RGC Calmar Ratio Rank: 5353
Calmar Ratio Rank
RGC Martin Ratio Rank: 4747
Martin Ratio Rank

DFDV
DFDV Risk / Return Rank: 1212
Overall Rank
DFDV Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
DFDV Sortino Ratio Rank: 1212
Sortino Ratio Rank
DFDV Omega Ratio Rank: 1515
Omega Ratio Rank
DFDV Calmar Ratio Rank: 44
Calmar Ratio Rank
DFDV Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RGC vs. DFDV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regencell Bioscience Holdings Limited (RGC) and DeFi Development Corp (DFDV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RGCDFDVDifference
Sharpe ratioReturn per unit of total volatility

+0.74

Sortino ratioReturn per unit of downside risk

+4.34

Omega ratioGain probability vs. loss probability

1.44

0.90

+0.53

Calmar ratioReturn relative to maximum drawdown

0.56

-0.93

+1.49

Martin ratioReturn relative to average drawdown

0.67

-1.21

+1.89

RGC vs. DFDV - Sharpe Ratio Comparison

The current RGC Sharpe Ratio is 0.14, which is higher than the DFDV Sharpe Ratio of -0.60. The chart below compares the historical Sharpe Ratios of RGC and DFDV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


RGCDFDVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.14

-0.60

+0.74

Sharpe Ratio (All Time)

Calculated using the full available price history

0.49

-0.02

+0.50

Drawdowns

RGC vs. DFDV - Drawdown Comparison

The maximum RGC drawdown since its inception was -93.09%, roughly equal to the maximum DFDV drawdown of -92.25%. Use the drawdown chart below to compare losses from any high point for RGC and DFDV.


Loading charts...

Drawdown Indicators


RGCDFDVDifference

Max Drawdown

Largest peak-to-trough decline

-93.09%

-92.25%

-0.84%

Max Drawdown (1Y)

Largest decline over 1 year

-86.72%

-89.56%

+2.84%

Max Drawdown (3Y)

Largest decline over 3 years

-88.34%

Current Drawdown

Current decline from peak

-69.55%

-92.20%

+22.65%

Average Drawdown

Average peak-to-trough decline

-59.29%

-72.11%

+12.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

71.76%

68.54%

+3.22%

Volatility

RGC vs. DFDV - Volatility Comparison

The current volatility for Regencell Bioscience Holdings Limited (RGC) is 21.55%, while DeFi Development Corp (DFDV) has a volatility of 25.31%. This indicates that RGC experiences smaller price fluctuations and is considered to be less risky than DFDV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RGCDFDVDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.55%

25.31%

-3.76%

Volatility (6M)

Calculated over the trailing 6-month period

110.23%

83.96%

+26.27%

Volatility (1Y)

Calculated over the trailing 1-year period

344.85%

138.64%

+206.21%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

308.92%

520.77%

-211.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

308.92%

520.77%

-211.85%

Dividends

RGC vs. DFDV - Dividend Comparison

Neither RGC nor DFDV has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

RGC vs. DFDV - Financials Comparison

This section allows you to compare key financial metrics between Regencell Bioscience Holdings Limited and DeFi Development Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-2.00B-1.50B-1.00B-500.00M0.002021202220232024202520260
2.66M
(RGC) Total Revenue
(DFDV) Total Revenue
Values in USD except per share items

Frequently Asked Questions


RGC and DFDV have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DFDV has higher volatility (25.31%) compared to RGC (21.55%). In terms of maximum drawdown, RGC dropped -93.09% vs DFDV's -92.25%.

RGC currently has the higher Sharpe Ratio (0.14 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RGC and DFDV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer